Insider Trading History of Panorama Capital, L.p.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Panorama Capital, L.p. since 2012. The trader's CIK number is 1436021. At the time of the last reporting, Panorama Capital, L.p. was the 10% Owner of Auspex Pharmaceuticals, Inc.. (stock ticker symbol ASPX). Also see all insider trading activities at Auspex Pharmaceuticals, Inc..

Note that in the past Panorama Capital, L.P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Hyperion Therapeutics Inc (HPTX) by Panorama Capital, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 HPTX 550,000 $5,500,000 0 $0 0 $0

Yearly summary of insider trading at Auspex Pharmaceuticals, Inc. (ASPX) by Panorama Capital, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 ASPX 0 $0 270,000 $14,339,700 0 $0
2014 ASPX 333,334 $4,000,008 0 $0 0 $0


Insider trading activities at 2 companies by Panorama Capital, L.p.:

1. Hyperion Therapeutics Inc (HPTX)

2. Auspex Pharmaceuticals, Inc. (ASPX)

Table 1. Insider trading of Hyperion Therapeutics Inc (HPTX) by Panorama Capital, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-07-31 HPTX Buy 550,000 10.00 5,500,000

Table 2. Insider trading of Auspex Pharmaceuticals, Inc. (ASPX) by Panorama Capital, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-01-28 ASPX Sale 270,000 53.11 14,339,700
2014-02-10 ASPX Buy 333,334 12.00 4,000,008

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Panorama Capital, L.p. (10% Owner of Auspex Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.